Category: News
Post
Our Response to Coronavirus
As the outbreak of coronavirus (COVID-19) continues to evolve, FHC has increased our level of awareness and are working to…Post
Regional Sales Managers, Northeast, Midwest and Southwest Regions
The Regional Sales Manager (RSM), is accountable for daily sales, design and implementation/execution of tactical plans for the FHC products…Post
Clinical Application and Sales Specialists, Northeast, Midwest, Southwest and Western regions
The Clinical Applications and Sales Specialist (CASS), is responsible for all aspects of Procedural and Technical Support and will also…Post
FHC Partners with Neurotargeting to Offer New Solution for Epilepsy Treatment
BOWDOIN, ME – FHC, Inc. and Neurotargeting, LLC have released WayPoint™ Navigator 4.5 planning software, now allowing epileptologists, neurosurgeons, and…Post
FHC Announces Comprehensive Epilepsy Solutions for Neurosurgery
BOWDOIN, ME – According to the American Epilepsy Society, at least 30-40% of individuals don’t respond to current antiepileptic drugs,…Post
FHC Awarded 2019 People’s Bank Award
Last night, FHC was awarded the 2019 People’s United Bank Innovation and Technology Award at the 20th annual Maine Family…Post
Haer named FHC’s Chairman of the Board
FHC, Inc., a global manufacturer of products for the neuroscience industry, is pleased to announce that F. Andrew (Andy) Haer…Post
FHC Announces FDA Clearance for Guideline 5 System
BOWDOIN, ME – January 8, 2019 – FHC, Inc., announced today that is has received 510(k) clearance from the Food…Post
FHC products enable use of new surgical technique for Parkinson’s sufferers in Australia
Australia’s 9News recently featured a story about a new surgical approach, using FHC products, that is treating Australian patients affected…Post